TP53 and cancer: Since numerous cancers require cytosolic localization of proteins (e.g., NF-κB, p53, FOXO1, pRB), blocking the ability of the proteins to enter the cytoplasm results in increased nuclear accumulation, culminating in activation of the apoptosis pathway and leading to death of the cancer cell [41, 42].